Express Scripts Holding (ESRX) Stake Lowered by Global Endowment Management LP

Global Endowment Management LP reduced its position in Express Scripts Holding (NASDAQ:ESRX) by 14.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 52,760 shares of the company’s stock after selling 8,800 shares during the period. Express Scripts accounts for approximately 0.6% of Global Endowment Management LP’s portfolio, making the stock its 24th largest holding. Global Endowment Management LP’s holdings in Express Scripts were worth $3,938,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Van ECK Associates Corp increased its position in shares of Express Scripts by 5.1% during the third quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock valued at $32,072,000 after buying an additional 24,728 shares during the period. Victory Capital Management Inc. boosted its stake in Express Scripts by 12.5% in the third quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after buying an additional 3,940 shares in the last quarter. Hendershot Investments Inc. purchased a new stake in Express Scripts in the third quarter worth approximately $5,132,000. Crossmark Global Holdings Inc. purchased a new stake in Express Scripts in the third quarter worth approximately $3,708,000. Finally, LMR Partners LLP purchased a new stake in Express Scripts in the third quarter worth approximately $3,230,000. Institutional investors and hedge funds own 86.45% of the company’s stock.

Shares of Express Scripts Holding (ESRX) opened at $74.72 on Friday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $83.49. The company has a market capitalization of $42,948.07, a price-to-earnings ratio of 11.09, a PEG ratio of 0.81 and a beta of 0.93.

Express Scripts announced that its board has approved a stock repurchase plan on Monday, December 18th that allows the company to buyback 45,000,000 outstanding shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its stock is undervalued.

In related news, VP Christine Houston sold 10,104 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Glen D. Stettin sold 3,448 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The disclosure for this sale can be found here. Insiders have sold 17,001 shares of company stock worth $1,249,505 over the last ninety days. 0.68% of the stock is currently owned by insiders.

ESRX has been the subject of a number of analyst reports. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, December 4th. Deutsche Bank assumed coverage on Express Scripts in a report on Monday, December 4th. They set a “buy” rating and a $75.00 target price for the company. Jefferies Group reiterated a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Finally, SunTrust Banks set a $82.00 price objective on Express Scripts and gave the stock a “buy” rating in a report on Thursday, December 14th. Five investment analysts have rated the stock with a sell rating, seven have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and a consensus price target of $78.93.

TRADEMARK VIOLATION WARNING: “Express Scripts Holding (ESRX) Stake Lowered by Global Endowment Management LP” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/23/express-scripts-holding-esrx-stake-lowered-by-global-endowment-management-lp.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply